The quarter beat the clearest published benchmark. Q2 net sales were $496.4m, about 2.5% above the published consensus of roughly $484.3m. That is a real beat, though not a dramatic one; the market already expected backlog conversion to accelerate in the second quarter.
| Metric | Q2 2026 | Comparison / expectation |
|---|---|---|
| Order intake | $516m | +16% vs. Q2 2025 (Financial Highlights) |
| Order backlog | $1,279m | +20% vs. June 30, 2025 (Financial Highlights) |
| Net sales | $496.4m | +9% vs. Q2 2025; vs. ~$484.3m consensus (Financial Highlights) |
| Net income | $10.5m | vs. $(7.9)m in Q2 2025 (Financial Highlights) |
| Adjusted EBITDA | $42.1m | +22% vs. Q2 2025; 8.5% margin (Combined Financial Summary) |
| Net debt | $450.4m | Down from $454.8m at Q1-end (Net Debt and Leverage) |
| Net debt leverage | 2.72x | vs. 3.28x a year earlier (Net Debt and Leverage) |
The operating improvement is broader than the headline revenue beat. Order intake rose 16%, backlog expanded 20%, and adjusted EBITDA grew more than twice as fast as sales, showing that the production ramp-up and integration savings are beginning to convert into profitability. The company also moved from a $7.9m quarterly loss to $10.5m of net income.
The backlog story is becoming tangible rather than merely aspirational. Sales grew 11% organically in North America and 7% in Europe and the rest of the world, while management said revenue should increase sequentially through the remainder of 2026. 〔0〕 This supports the existing growth thesis, but the direction was already well telegraphed by the large backlog and the prior quarter's commentary.
Full-year operating guidance was reaffirmed, not raised. The company kept 2026 net sales guidance at $1.95bn-$2.15bn and adjusted EBITDA guidance at $175m-$195m. That makes the quarter better than expectations on reported revenue, but not an outlook reset; the market had already been told to expect this range.
The main offset is a softer deleveraging endpoint. Earlier 2026 guidance called for year-end leverage at or below 2.0x, while this release now says 2.0x or slightly above, citing temporary supply-chain and margin-protection investments. Debt fell only $5m from Q1 despite the stronger quarter, so the balance-sheet improvement is progressing but less cleanly than previously framed. Netting that against the revenue beat, margin expansion, and reaffirmed earnings outlook leaves a narrowly positive read rather than a major upside surprise.
Read the original 8-K on SEC EDGAR ↗